LYVE1 Antikörper (AA 25-235)
Kurzübersicht für LYVE1 Antikörper (AA 25-235) (ABIN121151)
Target
Alle LYVE1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 25-235
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Protein-G affinity chromatography
-
Immunogen
- Recombinant human LYVE-1 (25-235 aa) purified from E. coli
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
-
ELISA. Western blot (is 1:500 - 1:1,000).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS, pH 7.4 containing 0.01 % Sodium azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
-
Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
Shelf Life: one year from despatch. -
Haltbarkeit
- 12 months
-
-
- LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))
-
Andere Bezeichnung
- LYVE-1
-
Hintergrund
- Lymphatic vascular endothelial hyaluronan receptor-1(LYVE-1), a selective marker of the lymphatic endothelium, is a surface endocytic receptor for hyaluronan (HA), which is an extracellular glycosaminoglycan involved in cell adhesion and migration. HA is widely expressed on leukocytes, dendritic cells, and tumor cell, and is identified by searching expressed sequence tag (EST) databases for sequences homologous (41 % ) with the metastasis related CD44 Molecules.Synonyms: CRSBP-1, CRSBP1, Cell surface retention sequence-binding protein 1, Extracellular link domain-containing protein 1, HAR, Hyaluronic acid receptor, LYVE1, Lymphatic vessel endothelial hyaluronic acid receptor 1, XLKD1
-
UniProt
- Q9Y5Y7
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-